返回 Agenda
Session Chair(s)
Geoffrey Saroea, DrMed, MD
Senior Medical Affairs Advisor
Novartis Consumer Health Canada Inc, Canada
Chanez Narimene Kebache, MBA
Director, Global Product Safety & Pharmacovigilance
Canopy Growth Corporation, Canada
Speaker(s)
Critical Path to Ensure Regulatory Compliance During Mergers and Acquisitions
Silvia Mamber, DrMed
Valeant Canada, Canada
Manager, Pharmacovigilance
Companion Diagnostics in Canada: Regulatory Considerations
Katherine M. Soltys, MD
Health Canada, Canada
Director, Office of Clinical Trials, Pharmaceutical Drug Directorate
Drug-Device Combinations - Regulatory and Other Considerations
Mary Speagle
Innomar Strategies Inc., Canada
Senior Director, Regulatory Affairs